Latest Breaking News On - Gal yadid - Page 2 : vimarsana.com

Clearmind Medicine (CMND) Reports Positive Pre-Clinical Results Treating Major Depression With a Novel Ketamine-Based Compound

Clearmind Medicine (CMND) Reports Positive Pre-Clinical Results Treating Major Depression With a Novel Ketamine-Based Compound
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesGal yadidAdi zuloff shaniClearmind medicine incIlan universityFrankfurt stock exchangeExchange commissionTrademark officeCanadian securities exchangeGonda multidisciplinary brain research centerBar ilan universityProfessor gal yadidMajor depressive disorderUnited states patentFlinders sensitive lineBoth ketamine

Israeli Biotech Clearmind Medicine Announces Positive Pre-Clinical Results Treating Major Depression With a Novel Ketamine-Based Compound

Tel Aviv, Israel / Vancouver, Canada, Jan. 31, 2023 Clearmind Medicine Inc. , , a biotech company focused on discovery and development of novel psychedelic-derived therapeutics to solve major. | January 31, 2023

United statesTel avivGal yadidAdi zuloff shaniClearmind medicine incIlan universityFrankfurt stock exchangeExchange commissionTrademark officeMedicine incCanadian securities exchangeGonda multidisciplinary brain research centerBar ilan universityProfessor gal yadidMajor depressive disorderUnited states patent

Israel-Based Clearmind Announces Additional Positive

The results of pre-clinical in-vivo research studies suggested that Clearmind's drug candidate MEAI may be effective in the treatment of substance.

Tel avivGal yadidAdi zuloff shaniExchange commissionClearmind medicine incCanadian securities exchangeFrankfurt stock exchangeProfessor gal yadidGonda multidisciplinary brain research centerBar ilan universityChief executivePrivate securities litigation reform actNasdaq cmndLearmind medicine inc

EQS-News: Can This Company s Positive Results For Psychedelic Combination Treatment Provide Hope For Alcohol And Cocaine Addiction Problems?

EQS-News: SciSparc Ltd. Can This Company’s Positive Results For Psychedelic Combination Treatment Provide Hope For Alcohol And Cocaine Addiction Problems? 15.11.2022 / 16:25 CET/CEST The issuer is solely responsible for the content of this announcement. Learn More about SciSparc Ltd. by gaining .

United statesScisparc cannamideGal yadidChristine petragliaNational centerScisparc ltdUnited nations office on drugsClearmind medicine incWorld health organizationAmphastar pharmaceuticals incDistribution servicesCan this company positiveBiocorrx incNews serviceViatris incHealth organization

EQS-News: SciSparc Ltd : Can This Company s Positive Results For Psychedelic Combination Treatment Provide Hope For Alcohol And Cocaine Addiction Problems?

EQS-News: SciSparc Ltd. Can This Company's Positive Results For Psychedelic Combination Treatment Provide Hope For Alcohol And Cocaine Addiction Problems? 15.11.2022 / 16:25 CET/CEST The

United statesScisparc cannamideGal yadidChristine petragliaNational centerScisparc ltdUnited nations office on drugsClearmind medicine incWorld health organizationAmphastar pharmaceuticals incDistribution servicesCan this company positiveBiocorrx incNews serviceViatris incHealth organization